A real-world study of treatment patterns and outcomes in US managed-care patients with type 2 Diabetes initiating injectable therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A real-world study of treatment patterns and outcomes in US managed-care patients with type 2 Diabetes initiating injectable therapies

Published:2017-01-20 Issue:3 Volume:19 Page:375-386
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Wei Wenhui¹,Buysman Erin²,Grabner Michael³,Xie Lin⁴,Brekke Lee²,Ke Xuehua³,Chu James W.⁵,Levin Philip A.⁶

Affiliation:

1. Sanofi US, Inc.; Bridgewater New Jersey

2. Optum; Eden Prairie Minnesota

3. HealthCore, Inc.; Wilmington Delaware

4. STATinMED Research; Ann Arbor Michigan

5. Monterey Endocrine & Diabetes Institute; Monterey California

6. MODEL Clinical Research; Baltimore Maryland

Funder

This study was funded by Sanofi US, Inc

Amylin Pharmaceuticals

AstraZeneca

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12828/fullpdf

Reference59 articles.

1. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34);UKPDS;Lancet,1998

2. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the american diabetes association and the european association for the study of diabetes;Inzucchi;Diabetes Care,2015

3. AACE/ACE comprehensive diabetes management algorithm;Garber;Endocr Pract,2015

4. Resistance to insulin therapy among patients and providers: results of the cross-national diabetes attitudes, wishes, and needs (DAWN) study;Peyrot;Diabetes Care,2005

5. Barriers to insulin initiation: the translating research into action for diabetes insulin starts project;Karter;Diabetes Care,2010

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Basal Insulinotherapy in Patients Living with Diabetes in France: The EF-BI Study;Diabetes Therapy;2024-04-20

2. Big Data and Real-World Data based Cost-Effectiveness Studies and Decision-making Models: A Systematic Review and Analysis;Frontiers in Pharmacology;2021-10-19

3. Switching from insulin to dulaglutide therapy in patients with type 2 diabetes: A real‐world data study;Diabetes/Metabolism Research and Reviews;2021-05-13

4. Treatment persistence in patients with type 2 diabetes treated with glucagon‐like peptide‐1 receptor agonists in clinical practice in Sweden;Diabetes, Obesity and Metabolism;2020-12-23

5. Diabetes-Related Effectiveness and Cost of Liraglutide or Insulin in German Patients with Type 2 Diabetes: A 5-Year Retrospective Claims Analysis;Diabetes Therapy;2020-09-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3